Related Experiment Video
Updated: Nov 2, 2025
06:43
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
10.1K
Cholinergic anti-inflammatory pathway and connective tissue diseases
Khalil Hajiasgharzadeh1,2, Alireza Khabbazi3, Ahad Mokhtarzadeh1
1Immunology Research Center, Tabriz University of Medical Sciences, Golgasht St, Postcode: 5166614766, Tabriz, Iran.
Inflammopharmacology
|June 14, 2021
Summary
The cholinergic anti-inflammatory pathway (CAP) may offer therapeutic benefits for connective tissue diseases (CTDs). However, autonomic neuropathy in CTDs can impact CAP efficiency, requiring further investigation for novel treatment strategies.
Area of Science:
- Immunology
- Rheumatology
- Neuroscience
Background:
- Connective tissue diseases (CTDs) involve chronic inflammation affecting bodily tissues.
- Existing treatments aim to reduce inflammation and organ damage in CTDs.
- The cholinergic anti-inflammatory pathway (CAP) is explored for its role in modulating inflammation.
Purpose of the Study:
- To review the role and therapeutic potential of CAP in CTDs.
- To highlight the impact of autonomic neuropathy on CAP efficacy in CTDs.
- To explore novel therapeutic strategies for CTDs based on CAP modulation.
Main Methods:
- Narrative review of existing literature.
- Searches conducted on Science Direct, PubMed, Google Scholar, and Web of Science.
- Analysis of experimental and clinical models evaluating CAP in CTDs.
Main Results:
- CAP shows potential in managing inflammation in CTDs.
- Autonomic neuropathy, common in CTDs, complicates CAP's effectiveness.
- The interplay between CAP and neuropathy in CTDs is complex and requires further study.
Conclusions:
- Understanding CAP's complex role in CTDs is crucial for developing new treatments.
- Targeting CAP, while considering autonomic neuropathy, may lead to improved therapeutic strategies for CTDs.
- Further research is needed to harness CAP for effective CTD management.
Keywords:
Cholinergic anti-inflammatory pathwayConnective tissue diseasesInflammation responseTherapeutic interventionMore Related Videos
Related Concept Videos
01:28Inflammatory Response
13.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
13.9K
01:30Parasympathetic Signaling
2.3K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
2.3K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.0K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.0K
01:24T Cell Types and Functions
1.6K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.6K
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.9K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.9K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
272
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
272